Parikh Asit — SEC Form 4 filings
SEC reporting owner CIK 1796787. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-27.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-05-24 to 2026-05-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 30,000 shares, $150,432 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: purchase of 10,000 shares @ $8.12 ($81,248) in Phathom Pharmaceuticals, Inc., filed 2024-12-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | Director | 12 | 4 legs · 30,000 sh · $150,432 | — | 19 |
Form 4 filings — Parikh Asit
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-27 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Gift (G): 28,000 @ $0 · Gift (G): 28,000 @ $0 | EDGAR |
| 2026-05-21 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 24,122 @ $0 · Option exercise (M): 17,500 @ $4.95 · Disposition to issuer (D): 17,500 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Gift (G): 40,000 @ $0 · Gift (G): 40,000 @ $0 | EDGAR |
| 2026-01-27 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Gift (G): 80,500 @ $0 · Gift (G): 80,500 @ $0 | EDGAR |
| 2026-01-15 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Option exercise (M): 8,750 @ $10.30 · Option exercise (M): 8,750 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Option exercise (M): 8,750 @ $10.30 · Option exercise (M): 8,750 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-05-08 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Purchase (P): 5,000 @ $2.60 · Purchase (P): 5,000 @ $2.40 | EDGAR |
| 2025-03-21 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Option exercise (M): 7,500 @ $11.72 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Purchase (P): 10,000 @ $4.42 | EDGAR |
| 2024-12-16 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Purchase (P): 10,000 @ $8.12 | EDGAR |
| 2024-05-24 | 4 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/award (A): 10,500 @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796787 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →